{"id":"https://openalex.org/W2104729679","doi":"https://doi.org/10.1200/jco.1992.10.8.1310","title":"Phase II study of liposomal muramyl tripeptide in osteosarcoma: the cytokine cascade and monocyte activation following administration.","display_name":"Phase II study of liposomal muramyl tripeptide in osteosarcoma: the cytokine cascade and monocyte activation following administration.","publication_year":1992,"publication_date":"1992-08-01","ids":{"openalex":"https://openalex.org/W2104729679","doi":"https://doi.org/10.1200/jco.1992.10.8.1310","mag":"2104729679","pmid":"https://pubmed.ncbi.nlm.nih.gov/1634921"},"language":"en","primary_location":{"id":"doi:10.1200/jco.1992.10.8.1310","doi":"https://doi.org/10.1200/jco.1992.10.8.1310","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.1992.10.8.1310","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113633440","display_name":"Eugenie S. Kleinerman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E S Kleinerman","raw_affiliation_strings":["Department of Cell Biology, University of Texas MD Anderson Cancer Center, Houston 77030"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cell Biology, University of Texas MD Anderson Cancer Center, Houston 77030","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"S F Jia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S F Jia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039503690","display_name":"James D. Griffin","orcid":"https://orcid.org/0000-0003-1823-7930","observed_orcids":["https://orcid.org/0000-0003-1823-7930"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Griffin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048397868","display_name":"Nita L. Seibel","orcid":"https://orcid.org/0000-0001-6259-7955","observed_orcids":["https://orcid.org/0000-0001-6259-7955"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N L Seibel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109915010","display_name":"Robert S. Benjamin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R S Benjamin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5109631250","display_name":"N Jaffe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Jaffe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.9032,"has_fulltext":false,"cited_by_count":157,"citation_normalized_percentile":{"value":0.96903006,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"10","issue":"8","first_page":"1310","last_page":"1316"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9653000235557556,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9653000235557556,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.02459999918937683,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12996","display_name":"Bacterial Cancer Therapy","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/osteosarcoma","display_name":"osteosarcoma","score":0.9319999814033508},{"id":"https://openalex.org/keywords/relapsed-osteosarcoma","display_name":"relapsed osteosarcoma","score":0.9440000057220459},{"id":"https://openalex.org/keywords/lung-metastasis","display_name":"lung metastasis","score":0.8069999814033508},{"id":"https://openalex.org/keywords/cytokine-induction","display_name":"cytokine induction","score":0.9169999957084656},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9649999737739563},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":1.0},{"id":"https://openalex.org/keywords/neopterin","display_name":"neopterin","score":0.746999979019165},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.9039999842643738},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.8820000290870667},{"id":"https://openalex.org/keywords/monocyte-activation","display_name":"monocyte activation","score":0.8569999933242798},{"id":"https://openalex.org/keywords/macrophage-activation","display_name":"macrophage activation","score":0.9409999847412109},{"id":"https://openalex.org/keywords/immunostimulatory-therapy","display_name":"immunostimulatory therapy","score":0.6890000104904175},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.6980000138282776}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9194496273994446},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.6811681985855103},{"id":"https://openalex.org/C2776603314","wikidata":"https://www.wikidata.org/wiki/Q908292","display_name":"Neopterin","level":2,"score":0.6265901923179626},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.5441778898239136},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5426914691925049},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4499474763870239},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42635053396224976},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.39953064918518066}],"mesh":[{"descriptor_ui":"D000119","descriptor_name":"Acetylmuramyl-Alanyl-Isoglutamine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000119","descriptor_name":"Acetylmuramyl-Alanyl-Isoglutamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000119","descriptor_name":"Acetylmuramyl-Alanyl-Isoglutamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001708","descriptor_name":"Biopterins","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D001708","descriptor_name":"Biopterins","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002097","descriptor_name":"C-Reactive Protein","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004337","descriptor_name":"Drug Carriers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004341","descriptor_name":"Drug Evaluation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D010714","descriptor_name":"Phosphatidylethanolamines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010714","descriptor_name":"Phosphatidylethanolamines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012516","descriptor_name":"Osteosarcoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012516","descriptor_name":"Osteosarcoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D012516","descriptor_name":"Osteosarcoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016260","descriptor_name":"Monocytes, Activated Killer","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D019798","descriptor_name":"Neopterin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.1992.10.8.1310","doi":"https://doi.org/10.1200/jco.1992.10.8.1310","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.1992.10.8.1310","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:1634921","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1634921","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G8855982416","display_name":"Liposome and Polycationic Gene Therapy for Osteosarcoma","funder_award_id":"R01CA042992","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W143127919","https://openalex.org/W1548491520","https://openalex.org/W1586938382","https://openalex.org/W1751952968","https://openalex.org/W1804587604","https://openalex.org/W1942565668","https://openalex.org/W1979486202","https://openalex.org/W1984116870","https://openalex.org/W1993889959","https://openalex.org/W2012597411","https://openalex.org/W2054941139","https://openalex.org/W2096980047","https://openalex.org/W2113290012","https://openalex.org/W2165314511","https://openalex.org/W2469937525"],"related_works":["https://openalex.org/W2152081024","https://openalex.org/W1981376615","https://openalex.org/W2249234462","https://openalex.org/W2069219181","https://openalex.org/W4237682455","https://openalex.org/W83297993","https://openalex.org/W1853090251","https://openalex.org/W2037617841","https://openalex.org/W4281698826","https://openalex.org/W2096321265"],"abstract_inverted_index":{"PURPOSE:":[0],"A":[1],"phase":[2],"II":[3],"trial":[4],"that":[5,60,67,282,292],"uses":[6],"liposome-encapsulated":[7],"muramyl":[8],"tripeptide":[9],"phosphatidylethanolamine":[10],"(L-MTP-PE)":[11],"in":[12,22,29,94,177,193,220,248,266,288],"patients":[13,44,250,289],"with":[14,290],"relapsed":[15],"osteosarcoma":[16,56,291],"is":[17,280],"underway.":[18],"To":[19],"determine":[20],"if":[21],"vivo":[23],"cytokine":[24,40,132],"induction":[25,160,240],"plays":[26],"a":[27,104,108,115],"role":[28],"the":[30,38,86,91,153,207,221,239,275,297],"mechanism":[31],"of":[32,34,42,85,155,161,179,197,210,241],"action":[33],"L-MTP-PE,":[35,156],"we":[36],"investigated":[37],"circulating":[39,162,198,242,260],"levels":[41,133,169,185,224],"16":[43,180],"who":[45],"were":[46,68,77,123,129,186,235],"undergoing":[47],"therapy.":[48],"PATIENTS":[49],"AND":[50],"METHODS:":[51],"Patients":[52,76],"had":[53],"histologically":[54],"proven":[55],"and":[57,72,128,165,201,234,254,263,269,301],"pulmonary":[58],"metastases":[59],"developed":[61],"either":[62],"during":[63,103],"adjuvant":[64],"chemotherapy":[65],"or":[66],"present":[69],"at":[70,188,226,251],"diagnosis":[71],"persisted":[73],"despite":[74],"chemotherapy.":[75],"rendered":[78],"disease-free":[79,92],"by":[80,256],"surgery.":[81],"The":[82],"major":[83],"goal":[84],"study":[87],"was":[88,101,158,203,218,246],"to":[89,172,190,238,296],"improve":[90],"interval":[93],"this":[95],"high-risk":[96],"group.":[97],"L-MTP-PE":[98,126,283],"2":[99,173,189],"mg/m2":[100],"infused":[102],"1-hour":[105],"period":[106],"twice":[107],"week":[109,116],"for":[110,117,131],"12":[111,118],"weeks,":[112],"then":[113],"once":[114],"weeks.":[119],"Serial":[120],"blood":[121],"samples":[122],"collected":[124],"after":[125,175,206],"administration":[127],"assayed":[130],"(tumor":[134],"necrosis":[135],"factor-alpha":[136],"[TNF":[137],"alpha]":[138],"interleukin-1":[139],"alpha":[140,164,168,200,214,262],"[IL-1":[141],"alpha],":[142],"IL-1":[143,213,216],"beta,":[144],"IL-6,":[145,264],"interferon-gamma":[146],"[IFN-gamma],":[147],"neopterin,":[148],"C-reactive":[149,244,267],"protein).":[150],"RESULTS:":[151],"After":[152],"infusion":[154,176],"there":[157],"rapid":[159],"TNF":[163,167,199,261],"IL-6.":[166],"peaked":[170],"1":[171],"hours":[174,192,228,253],"10":[178],"patients,":[181],"whereas":[182],"peak":[183],"IL-6":[184,202],"detected":[187,219,273],"3":[191],"all":[194,249],"patients.":[195],"Induction":[196],"evident":[204],"only":[205],"first":[208],"dose":[209],"L-MTP-PE.":[211],"Neither":[212],"nor":[215],"beta":[217],"plasma.":[222],"Neopterin":[223],"increased":[225],"24":[227,252],"postinfusion,":[229],"which":[230],"indicated":[231],"macrophage":[232],"activation,":[233],"not":[236],"related":[237],"IFN-gamma.":[243],"protein":[245,268],"elevated":[247],"decreased":[255],"72":[257],"hours.":[258],"Unlike":[259],"elevations":[265],"neopterin":[270],"could":[271],"be":[272,294],"throughout":[274],"treatment":[276],"course.":[277],"CONCLUSION:":[278],"It":[279],"concluded":[281],"has":[284],"specific":[285],"biologic":[286],"effects":[287],"may":[293],"important":[295],"drug's":[298],"immunostimulatory":[299],"capacity":[300],"its":[302],"effectiveness":[303],"as":[304],"an":[305],"antitumor":[306],"agent.":[307]},"counts_by_year":[{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}